Table 4.
Association between alterations in BAI, BDI-II and PSQI, and higher scores in SF-36 and EQ-VAS, by univariable linear regression
PCS | MCS | EQ-VAS | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
beta | 95%CI | p- value | beta | 95%CI | p- value | beta | 95%CI | p- value | ||||
BAI* | -0.84 | -1.04 | -0.65 | < 0.001 | -0.93 | -1.11 | -0.75 | < 0.001 | -0.59 | -0.74 | -0.44 | < 0.001 |
BDI-II* | -1.10 | -1.32 | -0.88 | < 0.001 | -1.22 | -1.42 | -1.01 | < 0.001 | -0.74 | -0.91 | -0.57 | < 0.001 |
PSQI* | -0.29 | -0.50 | -0.08 | 0.007 | -0.22 | -0.43 | -0.01 | 0.037 | -0.24 | -0.39 | -0.08 | 0.004 |
PCS physical components score of the SF-36, MCS mental components score of the Short-Form 36-item questionnaire, EQ-VAS Visual Analogue Scale score of the EQ-5D, CI confidence interval, BAI the Beck Anxiety Inventory, BDI-II the Beck Depression Inventory, PSQI the Pittsburgh Sleep Quality Index. *evaluated in a subgroup of 265 participants